Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonard Saltz

Showing results (31-40 of 167) with videos related to

Pageof 17
Sort By:
Clinical Trials (London, England)|January 29, 2019
Challenges and solutions in the design and execution of the PROSPECT Phase II/III neoadjuvant rectal cancer trial (NCCTG N1048/Alliance)Deborah Schrag, Martin Weiser, Leonard Saltz, et al.
Investigational New Drugs|January 30, 2018
First-in-human phase I dose escalation study of MK-8033 in patients with advanced solid tumorsVicki L Keedy, Heinz-Josef Lenz, Leonard Saltz, et al.
JCO Oncology Practice|December 22, 2021
The Hardest Weeks of My Life: A Qualitative Study of Experiences, Practice Changes, and Emotional Burden of New York City Oncology Physicians During the COVID-19 Surge in 2020Kathleen A Lynch, Angela Green, Leonard Saltz, et al.
Journal of the National Cancer Institute|August 16, 2020
Recommendations for Testing and Treating Outpatient Cancer Patients in the Era of COVID-19Diane Reidy-Lagunes, Leonard Saltz, Michael Postow, et al.
Journal of the American College of Radiology : JACR|July 3, 2007
ACR Appropriateness Criteria on treatment of anal cancerMatthew M Poggi, W Warren Suh, Leonard Saltz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2005
Distal cT2N0 rectal cancer: is there an alternative to abdominoperineal resection?Ramesh Rengan, Philip Paty, W Douglas Wong, et al.
Journal of the American Academy of Dermatology|August 4, 2009
A prospective randomized trial of topical pimecrolimus for cetuximab-associated acnelike eruptionAlon Scope, Jocelyn A Lieb, Stephen W Dusza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2010
Disease course patterns after discontinuation of bevacizumab: pooled analysis of randomized phase III trialsDavid Miles, Nadia Harbeck, Bernard Escudier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2017
Clinical Features and Outcomes of Patients with Colorectal Cancers Harboring NRAS MutationsAndrea Cercek, Maria Ignez Braghiroli, Joanne F Chou, et al.
Anti-Cancer Drugs|March 12, 2004
Phase I trial of sequential raltitrexed followed by bolus 5-fluorouracil in patients with advanced colorectal cancerGary K Schwartz, Joseph Bertino, Nancy Kemeny, et al.
Pageof 17

Showing results (31-40 of 167) with videos related to

Sort By:
Pageof 17
Clinical Trials (London, England)|January 29, 2019
Challenges and solutions in the design and execution of the PROSPECT Phase II/III neoadjuvant rectal cancer trial (NCCTG N1048/Alliance)Deborah Schrag, Martin Weiser, Leonard Saltz, et al.
Investigational New Drugs|January 30, 2018
First-in-human phase I dose escalation study of MK-8033 in patients with advanced solid tumorsVicki L Keedy, Heinz-Josef Lenz, Leonard Saltz, et al.
JCO Oncology Practice|December 22, 2021
The Hardest Weeks of My Life: A Qualitative Study of Experiences, Practice Changes, and Emotional Burden of New York City Oncology Physicians During the COVID-19 Surge in 2020Kathleen A Lynch, Angela Green, Leonard Saltz, et al.
Journal of the National Cancer Institute|August 16, 2020
Recommendations for Testing and Treating Outpatient Cancer Patients in the Era of COVID-19Diane Reidy-Lagunes, Leonard Saltz, Michael Postow, et al.
Journal of the American College of Radiology : JACR|July 3, 2007
ACR Appropriateness Criteria on treatment of anal cancerMatthew M Poggi, W Warren Suh, Leonard Saltz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2005
Distal cT2N0 rectal cancer: is there an alternative to abdominoperineal resection?Ramesh Rengan, Philip Paty, W Douglas Wong, et al.
Journal of the American Academy of Dermatology|August 4, 2009
A prospective randomized trial of topical pimecrolimus for cetuximab-associated acnelike eruptionAlon Scope, Jocelyn A Lieb, Stephen W Dusza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2010
Disease course patterns after discontinuation of bevacizumab: pooled analysis of randomized phase III trialsDavid Miles, Nadia Harbeck, Bernard Escudier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2017
Clinical Features and Outcomes of Patients with Colorectal Cancers Harboring NRAS MutationsAndrea Cercek, Maria Ignez Braghiroli, Joanne F Chou, et al.
Anti-Cancer Drugs|March 12, 2004
Phase I trial of sequential raltitrexed followed by bolus 5-fluorouracil in patients with advanced colorectal cancerGary K Schwartz, Joseph Bertino, Nancy Kemeny, et al.
Pageof 17